Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study

• Yuliya Lytvyn, PhD,
• Hiba Zaaroura, MD,
• Asfandyar Mufti, MD,
• Shaikhah AlAbdulrazzaq, MD,
• Jensen Yeung, MD, FRCPC

Affiliations

Yuliya Lytvyn, PhD

Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Hiba Zaaroura, MD

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Asfandyar Mufti, MD

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Shaikhah AlAbdulrazzaq, MD

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Jensen Yeung, MD, FRCPC

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada; Probity Medical Research Inc, Waterloo, Ontario, Canada; Correspondence to: Jensen Yeung, MD, FRCPC, Division of Dermatology, Women's College Hospital, 76 Grenville St, Fifth Floor, Toronto, ON M5S 1B2, Canada